Delivery Order SPE2DB20D1004-SPE2DB24FG4T8

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,870.49 Firm Fixed Price delivery order contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 mcg inhalers. The $12,265.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,711.60 Firm Fixed Price Delivery Order covers the supply of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,493.95 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,346.56 firm fixed-price Delivery Order covers the supply of Advair HFA 115-21 MCG Inhaler 12GM to support military healthcare programs. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.78 firm fixed-price delivery order is for the supply of an Advair HFA 45-21 MCG inhaler, a specialty medication used for the treatment of respiratory conditions. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,747.87 firm-fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,469.01 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,206.74 firm-fixed-price delivery order is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a critical respiratory medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,047.74 firm fixed-price delivery order is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication used to treat respiratory conditions. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG4T8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,570.95 firm fixed price delivery order is for the supply of Advair HFA 230-21 MCG inhalers, a critical medication for the treatment of respiratory conditions. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a period of performance through July 2024 and does not include any set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in distributing a wide array of medical commodities, including specialty medications, vaccines, and medical devices, position the company as a key vendor for federal healthcare procurement, particularly within the military and veterans' healthcare systems.

Generated 2/27/25, 11:14 AM